Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis
2010; American Association for the Advancement of Science; Volume: 2; Issue: 52 Linguagem: Inglês
10.1126/scitranslmed.3001107
ISSN1946-6242
AutoresWolfgang Hueber, Dhavalkumar D. Patel, Thaddeus P. Dryja, A. Wright, Irina Koroleva, Gerard Bruin, Christian Antoni, Zoe Draelos, Michael H. Gold, Patrick Durez, Paul P. Tak, Juan J. Gómez‐Reino, C. Stephen Foster, Rosa Y. Kim, C. Michael Samson, Naomi S. Falk, David Chu, David Callanan, Quan Dong Nguyen, Kristine Rose, Asifa Haider, Franco Di Padova,
Tópico(s)Autoimmune Bullous Skin Diseases
ResumoA human antibody to interleukin-17A is well tolerated and may be effective in the treatment of psoriasis, rheumatoid arthritis, and noninfectious uveitis.
Referência(s)